JPH08134090A - Galactosyl kojic acid, its production and tyrosinase-inhibiting agent containing the same - Google Patents

Galactosyl kojic acid, its production and tyrosinase-inhibiting agent containing the same

Info

Publication number
JPH08134090A
JPH08134090A JP30283894A JP30283894A JPH08134090A JP H08134090 A JPH08134090 A JP H08134090A JP 30283894 A JP30283894 A JP 30283894A JP 30283894 A JP30283894 A JP 30283894A JP H08134090 A JPH08134090 A JP H08134090A
Authority
JP
Japan
Prior art keywords
kojic acid
tyrosinase
galactosyl
compound
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP30283894A
Other languages
Japanese (ja)
Inventor
Kazuhiro Nakanishi
一弘 中西
Masayuki Takenawa
誠之 竹縄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP30283894A priority Critical patent/JPH08134090A/en
Publication of JPH08134090A publication Critical patent/JPH08134090A/en
Pending legal-status Critical Current

Links

Landscapes

  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: To obtain a new galactosyl kojic acid having a tyrosinase-inhibiting action and a melamine production-inhibiting action and useful as an oxidation and black coloration-preventing agent for foods, a beautifully whitening agent for cosmetics, etc., by reacting kojic acid with lactose in the presence of an enzyme. CONSTITUTION: This new galactosyl kojic acid represented by formula I resolves problems such as solubility in water and stability, has a tyrosinase-inhibiting action and a melamine production-inhibiting action, and is useful as an oxidation and black coloration-preventing agent, a beautifully whitening agent for cosmetics, etc. The compound is obtained as galactopyranosyl-β-0-2-methyl-5- hydroxy-γ-pyrone by reacting kojic acid of formula II with lactose in the presence of an immobilized enzyme in a 0.1M phosphoric acid buffer solution (pH6.0) at 40 deg.C for 12hr. The immobilized enzyme is obtained by immobilizing β- galactosidase on a ceramic carrier with glutaraldehyde.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、チロシナ−ゼ阻害を有
する新規なガラクトシルコウジ酸に関するものであり、
食品用および化粧品用の分野で利用される。。
The present invention relates to a novel galactosyl kojic acid having tyrosinase inhibition,
It is used in the fields of food and cosmetics. .

【0002】[0002]

【従来の技術】コウジ酸は味噌、醤油、酒などに色や風
味を与えるコウジカビの培養液から単離されたもので、
鉄などの金属とのキレ−ト形成機能、酸化防止機能、紫
外線吸収機能、抗菌性、美白作用などの機能が明らかに
されている。コウジ酸はチロシンやド−パなどの酸化を
触媒するチロシナ−ゼに対する阻害作用を有しており、
この作用を利用して食品の黒変防止剤に、また顕著なメ
ラニン生成抑制作用を有することを利用して化粧品の美
白剤にも使用されている。
BACKGROUND OF THE INVENTION Kojic acid is isolated from a culture solution of Aspergillus niger, which gives color and flavor to miso, soy sauce, sake and the like.
Functions such as chelate forming function with metals such as iron, antioxidant function, ultraviolet absorbing function, antibacterial property, and whitening effect have been clarified. Kojic acid has an inhibitory effect on tyrosinase which catalyzes the oxidation of tyrosine and doper,
It is used as an anti-blackening agent in foods by utilizing this action, and also as a whitening agent in cosmetics because it has a remarkable inhibitory action on melanin production.

【0003】しかし、コウジ酸は溶解度が比較的低く
(水に対する溶解度8%)、安定性も低いなどの問題が
あり、食品用酸化・黒変防止剤、化粧品用美白剤として
は十分満足するものではない。
However, kojic acid has problems such as relatively low solubility (solubility in water of 8%) and low stability, and it is sufficiently satisfactory as an antioxidant for antioxidants and blackening in foods and a whitening agent for cosmetics. is not.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、コウ
ジ酸の水に対する溶解度、安定性などの問題点を解決
し、チロシナ−ゼに対する阻害作用を有する新規化学物
質を提供することである。
An object of the present invention is to solve the problems such as solubility and stability of kojic acid in water, and to provide a novel chemical substance having an inhibitory effect on tyrosinase.

【0005】[0005]

【課題を解決するための手段】本発明の発明者らは、コ
ウジ酸に乳糖を付加結合させることで、この問題点が改
良されることを見出だし、本発明を完成した。すなわ
ち、本発明はコウジ酸の溶解度、安定性などの問題点を
解決し、チロシナ−ゼに対する阻害作用を有する新規化
合物ガラクトシルコウジ酸に関するものである。本発明
の目的とするガラクトシルコウジ酸は新規であり、下記
式(I)で示される新規物質である。
The inventors of the present invention have found that this problem can be ameliorated by additionally binding lactose to kojic acid, and completed the present invention. That is, the present invention relates to a novel compound galactosyl kojic acid which solves problems such as solubility and stability of kojic acid and has an inhibitory effect on tyrosinase. Galactosyl kojic acid, which is the object of the present invention, is novel and is a novel substance represented by the following formula (I).

【0006】目的化合物(I)の好適な塩としては、例
えばアルカリ金属塩(例えば、ナトリウム塩、カリウム
塩、セシウム塩等)、アルカリ土類金属塩(例えば、カ
ルシウム塩、マグネシウム塩等)等の金属塩、アンモニ
ウム塩、有機塩基との塩(例えば、トリメチルアミン
塩、トリエチルアミン塩、ピリジン塩、ピコリン塩、エ
タノ−ルアミン塩、トリエタノ−ルアミン塩、ジシクロ
ヘキシルアミン塩、N,N’−ジベンジルエチレンジア
ミン塩等)、アミノ酸との塩(例えば、アルギニン塩、
アスパラギン酸塩、グルタミン酸塩等)等が挙げられ
る。
Suitable salts of the target compound (I) include, for example, alkali metal salts (eg sodium salt, potassium salt, cesium salt etc.), alkaline earth metal salts (eg calcium salt, magnesium salt etc.) and the like. Metal salts, ammonium salts, salts with organic bases (for example, trimethylamine salt, triethylamine salt, pyridine salt, picoline salt, ethanolamine salt, triethanolamine salt, dicyclohexylamine salt, N, N′-dibenzylethylenediamine salt, etc. ), Salts with amino acids (eg, arginine salts,
Aspartate, glutamate, etc.) and the like.

【0007】目的化合物(I)またはその塩は、下記の
反応式で示される方法によって製造することができる。
The object compound (I) or a salt thereof can be produced by the method represented by the following reaction formula.

【0008】目的化合物(I)またはその塩は、化合物
(II)を化合物(III)またはその塩と反応させる
ことによって製造することができる。化合物(II)及
び化合物(III)が天然物の場合は好ましくはβ−ガ
ラクトシダ−ゼの存在下、化合物(II)を化合物(I
II)またはその塩と反応させることによって製造する
ことができる。
The object compound (I) or its salt can be prepared by reacting the compound (II) with the compound (III) or its salt. When compound (II) and compound (III) are natural products, compound (II) is preferably added to compound (I) in the presence of β-galactosidase.
It can be produced by reacting with II) or a salt thereof.

【0009】化合物(III)の好適な塩としては、化
合物(I)で例示したものと同じものを挙げることがで
きる。この方法の原料化合物(II)および(III)
は、公知の化合物であり、市販されているものを用いる
ことができる。
Suitable salts of the compound (III) may be the same as those exemplified for the compound (I). Starting compounds (II) and (III) of this method
Is a known compound, and a commercially available one can be used.

【0010】この反応を酵素的合成により行う場合は、
例えば公知のβ−ガラクトシダ−ゼを用いることがで
き、そのような酵素の好適な例としてBacillus
circulans 起源のβ−ガラクトシダ−ゼが
挙げられる。この反応は、β−ガラクトシダ−ゼを常法
により、担体に固定化し、これに化合物(II)を化合
物(III)またはその塩と反応させ、目的化合物
(I)を製造する方法が好適である。
When this reaction is carried out by enzymatic synthesis,
For example, known β-galactosidase can be used, and as a suitable example of such an enzyme, Bacillus
Examples include β-galactosidase derived from circulans. In this reaction, β-galactosidase is immobilized on a carrier by a conventional method, and the compound (II) is reacted with the compound (III) or a salt thereof to produce the target compound (I). .

【0011】反応温度は特に限定されず、通常、室温ま
たは加温下で反応は行われる。上記製造法で得られた化
合物(I)は、常法により単離、精製することができ
る。目的化合物(I)(ガラクトシルコウジ酸)の収率
は、化合物(II)と化合物(III)またはその塩の
濃度とともに増加する。
The reaction temperature is not particularly limited, and the reaction is usually carried out at room temperature or under heating. The compound (I) obtained by the above production method can be isolated and purified by a conventional method. The yield of the target compound (I) (galactosyl kojic acid) increases with the concentrations of the compound (II) and the compound (III) or a salt thereof.

【0012】本発明の目的化合物(I)は、チロシナー
ゼ阻害活性を有し、たとえば食品の黒変防止剤、化粧品
等として有用である。例えば化粧品の美白剤として化粧
水、クリ−ム、乳液、パック等の皮膚化粧料に含有させ
ることができる。それらの各化粧料は、通常使用される
化粧料基剤、助剤等に目的化合物(I)を0.01〜1
%加えて製造することができる。化粧水は、精製水にグ
リセリンのような保湿剤、皮膚栄養剤等を溶解し、防腐
剤、香料等をアルコ−ルに溶解し、両者を混合して室温
下に可溶化させ、アルコ−ル部に目的化合物(I)を
0.01〜1%になるように加えて製造することができ
る。
The object compound (I) of the present invention has a tyrosinase inhibitory activity and is useful, for example, as a blackening inhibitor for foods, cosmetics and the like. For example, it can be contained in skin cosmetics such as lotion, cream, emulsion and pack as a whitening agent for cosmetics. Each of these cosmetics contains 0.01 to 1 of the target compound (I) in a commonly used cosmetic base, auxiliary agent or the like.
% Can be added to manufacture. A lotion is prepared by dissolving a moisturizing agent such as glycerin, a skin nutrition agent, etc. in purified water, preservatives, fragrances, etc. in alcohol, mixing both of them and solubilizing them at room temperature. Particular amount of the target compound (I) can be added so as to be 0.01 to 1%.

【0013】[0013]

【発明の効果】目的化合物(I)の有用性を示すため
に、目的化合物(I)のチロシナ−ゼ阻害活性試験デ−
タを次に示す。 試験 チロシナ−ゼ阻害活性 (1)試験方法 50mM−リン酸緩衝液(pH6.8)にL−DOPA
を6mMとなるように溶解した液2mlに、各種濃度の
コウジ酸またはガラクトシルコウジ酸溶液0.9mlを
加え、この混合液に10mg/ml濃度のチロシナ−ゼ
(和光純薬工業製チロシナ−ゼ5000)0.1mlを
加え吸光度測定用ガラスセルに移し、30℃で反応させ
た。この時の475nmの吸光度の変化を測定し、チロ
シナ−ゼ阻害剤無添加時の吸光度の変化との相対値から
阻害率を求めた。
INDUSTRIAL APPLICABILITY In order to show the usefulness of the target compound (I), a data of a test for tyrosinase inhibitory activity of the target compound (I).
Data is shown below. Test Tyrosinase inhibitory activity (1) Test method L-DOPA was added to 50 mM-phosphate buffer (pH 6.8).
0.9 ml of a solution of kojic acid or galactosyl kojic acid having various concentrations was added to 2 ml of a solution prepared by dissolving 6 mM of 6 mM, and 10 mg / ml of tyrosinase (Tyrosinase 5000 manufactured by Wako Pure Chemical Industries, Ltd. was added to this mixed solution. ) 0.1 ml was added and the mixture was transferred to a glass cell for measuring absorbance and reacted at 30 ° C. The change in absorbance at 475 nm at this time was measured, and the inhibition rate was calculated from the relative value with respect to the change in absorbance when no tyrosinase inhibitor was added.

【0014】(2)試験結果 ガラクトシルコウジ酸のチロシナ−ゼ阻害活性は表1に
示す通りであり、コウジ酸のチロシナ−ゼ阻害活性とほ
ぼ一致する。
(2) Test Results The tyrosinase inhibitory activity of galactosyl kojic acid is shown in Table 1, which is almost the same as the tyrosinase inhibitory activity of kojic acid.

【0015】[0015]

【表1】 本発明の目的化合物(I)ガラクトシルコウジ酸は、コ
ウジ酸よりも水への溶解度及び安定性が大であり、且つ
コウジ酸と同様チロシンやド−パなどの酸化を触媒する
チロシナ−ゼに対する活性阻害作用を有しており、この
作用を利用して食品の黒変防止剤に、また顕著なメラニ
ン生成抑制作用を有することを利用して化粧品の美白剤
にも使用されることができる。
[Table 1] The object compound (I) of the present invention, galactosyl kojic acid, has greater solubility and stability in water than kojic acid, and, like kojic acid, has activity against tyrosinase which catalyzes the oxidation of tyrosine, dopa and the like. It has an inhibitory action, and by utilizing this action, it can be used as an anti-blackening agent for foods, and also as a whitening agent for cosmetics because it has a remarkable inhibitory action on melanin production.

【0016】以下、実施例に従って、この発明をさらに
詳細に説明する。
The present invention will be described in more detail below with reference to examples.

【0017】実施例1 (1)β−ガラクトシダ−ゼの固定化 固定化担体として、セラミック担体(日本ガイシ社製
SM−10−C2)を3%グルタルアルデヒド溶液で処
理し、これを0.1M−リン酸緩衝液(pH6.0)で
洗浄する。この担体を市販のβ−ガラクトシダ−ゼ(大
和化成社製、Bacillus circulans
起源)溶液に懸濁させ、4℃で17時間ゆるやかに振と
うし、酵素を担体に結合させる。これを0.1M−リン
酸緩衝液(pH6.0)で洗浄後、再び3%グルタルア
ルデヒド溶液を加えて4℃で3時間処理し酵素を固定化
する。この固定化酵素の力価は1グラム当りおよそ10
0単位であった。ここでβ−ガラクトシダ−ゼ酵素1単
位とは、乳糖濃度4.56%、pH6.0、反応温度4
0℃の条件で1分間に1μmolのグルコ−スを遊離す
る酵素量を意味する。
Example 1 (1) Immobilization of β-galactosidase As an immobilization carrier, a ceramic carrier (manufactured by NGK Insulators Co., Ltd.)
SM-10-C2) is treated with a 3% glutaraldehyde solution, which is washed with 0.1 M phosphate buffer (pH 6.0). Commercially available β-galactosidase (manufactured by Daiwa Kasei Co., Ltd., Bacillus circulans)
(Source) Suspend in solution and gently shake for 17 hours at 4 ° C. to bind enzyme to carrier. After washing this with 0.1 M phosphate buffer (pH 6.0), 3% glutaraldehyde solution is added again and treated at 4 ° C. for 3 hours to immobilize the enzyme. The titer of this immobilized enzyme is about 10 per gram.
It was 0 unit. Here, 1 unit of β-galactosidase enzyme means lactose concentration 4.56%, pH 6.0, reaction temperature 4
It means the amount of enzyme that liberates 1 μmol glucose in 1 minute under the condition of 0 ° C.

【0018】(2)ガラクトシルコウジ酸の合成 0.1M−リン酸緩衝液(pH6.0)にコウジ酸5
%、乳糖20%となるように溶解し、これに上記で調製
した酵素を0.1g/mlとなるように添加し40℃で
12時間反応させた。反応液は濾過し、濾液を高速液体
クロマトグラフィ−により分離・精製および定量した。
ガラクトシルコウジ酸の収率はコウジ酸に対して24%
であった。得られたガラクトシルコウジ酸は、下記のF
AB−マススペクトル、NMRおよび紫外吸収スペクト
ルのpH依存性から、ガラクトピラノシル−β−O−2
−メチル−5−ヒドロキシ−γ−ピロン(galact
opyranosyl−β−O−2−methyl−5
−hydroxy−γ−pyrone) と同定された。 分離・精製条件 カラム;YMC社製 YMC−Pack NH2(20
×250mm) 溶離液;アセトニトリル/水=40/60(v/v) 流量;3ml/min 定量条件 カラム;YMC社製 YMC−Pack N2(6×1
50mm) 溶離液;アセトニトリル/0.1M−リン酸緩衝液=3
0/70(v/v) 流量;0.8ml/min 検出 ;UV 280nm FAB Mass(m/z):303(M−1) NMR(D2O,δ):3.52−3.76(5H,
m),3.72(2H,s),3.91(1H,t,J
=2.5Hz),4.47(1H,d,J=7.6H
z),6.68(1H,s),8.07(1H,s)
(2) Synthesis of galactosyl kojic acid Kojic acid 5 was added to 0.1 M-phosphate buffer (pH 6.0).
%, Lactose 20%, and the enzyme prepared above was added to the solution at 0.1 g / ml and reacted at 40 ° C. for 12 hours. The reaction solution was filtered, and the filtrate was separated / purified and quantified by high performance liquid chromatography.
The yield of galactosyl kojic acid is 24% based on kojic acid.
Met. The obtained galactosyl kojic acid has the following F
From the pH dependence of AB-mass spectrum, NMR and ultraviolet absorption spectrum, galactopyranosyl-β-O-2
-Methyl-5-hydroxy-γ-pyrone (galact
opyranosyl-β-O-2-methyl-5
-Hydroxy-γ-pyrone) Was identified. Separation / purification conditions Column: YMC-made YMC-Pack NH 2 (20
X250 mm) Eluent; acetonitrile / water = 40/60 (v / v) Flow rate; 3 ml / min Quantitative conditions Column: YMC YMC-Pack N 2 (6 × 1)
50 mm) Eluent; acetonitrile / 0.1 M-phosphate buffer = 3
0/70 (v / v) flow rate; 0.8 ml / min detection; UV 280 nm FAB Mass (m / z): 303 (M-1) NMR (D 2 O, δ): 3.52-3.76 ( 5H,
m), 3.72 (2H, s), 3.91 (1H, t, J
= 2.5 Hz), 4.47 (1H, d, J = 7.6H)
z), 6.68 (1H, s), 8.07 (1H, s)

フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C12P 19/58 7432−4B Continuation of the front page (51) Int.Cl. 6 Identification number Office reference number FI technical display location C12P 19/58 7432-4B

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 式: で示される化合物またはその塩。1. The formula: Or a salt thereof. 【請求項2】 請求項1に記載の化合物またはその塩を
有効成分として含有するチロシナ−ゼ阻害剤
2. A tyrosinase inhibitor containing the compound according to claim 1 or a salt thereof as an active ingredient.
JP30283894A 1994-11-11 1994-11-11 Galactosyl kojic acid, its production and tyrosinase-inhibiting agent containing the same Pending JPH08134090A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP30283894A JPH08134090A (en) 1994-11-11 1994-11-11 Galactosyl kojic acid, its production and tyrosinase-inhibiting agent containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30283894A JPH08134090A (en) 1994-11-11 1994-11-11 Galactosyl kojic acid, its production and tyrosinase-inhibiting agent containing the same

Publications (1)

Publication Number Publication Date
JPH08134090A true JPH08134090A (en) 1996-05-28

Family

ID=17913711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP30283894A Pending JPH08134090A (en) 1994-11-11 1994-11-11 Galactosyl kojic acid, its production and tyrosinase-inhibiting agent containing the same

Country Status (1)

Country Link
JP (1) JPH08134090A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056838A1 (en) * 1999-03-19 2000-09-28 Danisco A/S Anti-oxidant
WO2002026061A1 (en) * 2000-09-27 2002-04-04 Danisco A/S Antimicrobial agent
US8772252B2 (en) 2011-01-27 2014-07-08 New York University Coumarin compounds as melanogenesis modifiers and uses thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056838A1 (en) * 1999-03-19 2000-09-28 Danisco A/S Anti-oxidant
US6846505B2 (en) 1999-03-19 2005-01-25 Danisco A/S Anti-oxidant
WO2002026061A1 (en) * 2000-09-27 2002-04-04 Danisco A/S Antimicrobial agent
GB2381456A (en) * 2000-09-27 2003-05-07 Danisco Antimicrobial agent
GB2381456B (en) * 2000-09-27 2004-08-04 Danisco An anhydrofructose derived antimicrobial agent
US8772252B2 (en) 2011-01-27 2014-07-08 New York University Coumarin compounds as melanogenesis modifiers and uses thereof

Similar Documents

Publication Publication Date Title
Frick et al. Transition state stabilization by deaminases: rates of nonenzymatic hydrolysis of adenosine and cytidine
Faria et al. Design of new enzyme stabilizers inspired by glycosides of hyperthermophilic microorganisms
Komoda et al. Specific inhibitor of puromycin-sensitive aminopeptidase with a homophthalimide skeleton: identification of the target molecule and a structure–activity relationship study
FR2813191A1 (en) New tocopherol derivatives containing 3-aminopropyl phosphate groups have useful physiological properties including skin healing and anti-ageing of biomembranes
JPH04311394A (en) Preparation of pyrocatechol system compound
JPH0322993A (en) Manufacture of water-soluble l-tyrosine derivative and l-tyrosine derivative
CN108033881B (en) Tyrosinase inhibitor from semi-natural source and preparation method and application thereof
Schou et al. Enzymatic formation of glutamohydroxamic acid from glutamine in mammalian tissue
JPH08134090A (en) Galactosyl kojic acid, its production and tyrosinase-inhibiting agent containing the same
SchÖTT et al. Purification and some properties of tryptophan synthase inactivase II from yeast
JP2792645B2 (en) Method for producing theanine
CN102964283B (en) 4-thiosemicarbazide formal benzyl (amino acid) amide compound and application thereof
JP3110075B2 (en) Method for producing composition containing angiotensin converting enzyme inhibitor
JP4307784B2 (en) Acylated derivatives of glycosyl-L-ascorbic acid and uses thereof
US5536838A (en) Method of synthesis of chromium amino acid nicotinate complex
JP2001316268A (en) Skin care preparation
JP2000186274A (en) Chelating agent
CN108727321A (en) Gallic acid kojic acid ester type compound and its application as tyrosinase inhibitor
Fu Para-[N-bis-(2-chloroethyl)]-aminobenzoylglutamic acid
JPH1179934A (en) Tyrosinase activity inhibiting composition, tyrosinase activity inhibitor, and bleaching solution and bath preparation using the same composition
JPH04273896A (en) Tripeptide derivative
JPH0143557B2 (en)
JPS61289017A (en) Skin cosmetic
JP4653333B2 (en) Method for producing indoles or indolines
JPH0482817A (en) Melanogenesis inhibitor